谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Safety, Efficacy, and Biomarker Results from an Open-Label, Multicenter, Phase 1 Study of RP2 Alone or Combined with Nivolumab in a Cohort of Patients with Uveal Melanoma.

Joseph J. Sacco,Kevin Joseph Harrington,Anna Olsson-Brown,Tze Y. Chan,Pablo Nenclares,Isla Leslie,Praveen Bommareddy, Alireza Kalbasi, Ben Xie, Moran Mishal, David Michael Cohan, Aglaia Skolariki,Mark R. Middleton

Journal of Clinical Oncology（2024）

引用 0|浏览2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要